Eversept Partners’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.28M Buy
+1,402,548
New +$3.44M 0.18% 67

Other funds holding STIM

Eversept Partners's STIM Position: Q3 2026 in Review

Eversept Partners opened a new position in Neuronetics (STIM) in Q3 2026: 1,402,548 shares worth $3.28M. The stake represents 0.18% of the portfolio and ranks #67 among its holdings.

71 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Eversept Partners held 1,402,548 shares of Neuronetics worth $3.28M as of Q3 2026.
  • Neuronetics was a new Eversept Partners position in Q3 2026.
  • Neuronetics made up 0.18% of Eversept Partners's portfolio in Q3 2026, its #67 holding.
  • 71 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.